Back to first-pass browser

First-pass extracted concept

immunocyte-derived extracellular vesicles

Candidate: concept label1 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

EVs, immunocyte-derived EVs

Extracted Explainers

What the tool is doing

Immunocyte-derived EVs are described as nanosized mediators that transport proteins, lipids, and RNAs to regulate bone remodeling. The abstract states that they modulate osteoblast and osteoclast activity through multiple immune-associated pathways.

Source 1DOIPubMed

What problem it solves

They provide a mechanism for communication between immune and skeletal systems in osteoimmunology. The source also frames them as biomarker and therapeutic candidates in bone disorders.

Source 1DOIPubMed

What it does not solve

The abstract indicates that these EVs can also worsen inflammation and bone resorption in osteoporosis, rheumatoid arthritis, and periodontitis. It also does not resolve standardization, production, or translation barriers.

Source 1DOIPubMed

Alternatives

The abstract contrasts native immunocyte-derived EV biology with engineered EV strategies such as cargo loading, surface modification, and biomaterial integration.

Source 1DOIPubMed

Evidence Snippets

Immunocyte-derived EVs modulate osteoblast and osteoclast activity through macrophage polarization, Treg-associated CD73/adenosine signaling, Th17/Treg balance, and B cell-bone interactions.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1biomarker and therapeutic potentialsupports2025Source 1DOIPubMed

Immunocyte-derived extracellular vesicles are highlighted as both biomarkers and therapeutic candidates in bone disorders.

Quoted textsource-backed
These insights highlight immunocyte-derived EVs as both biomarkers and therapeutic candidates in bone disorders
Claim 2context dependent effectsupports2025Source 1DOIPubMed

Immunocyte-derived extracellular vesicles have dual effects, promoting bone formation under physiological conditions while amplifying inflammation and bone resorption in osteoporosis, rheumatoid arthritis, and periodontitis.

Quoted textsource-backed
exerting dual effects by promoting bone formation under physiological conditions while amplifying inflammation and bone resorption in osteoporosis, rheumatoid arthritis, and periodontitis
Claim 3intercellular communicationsupports2025Source 1DOIPubMed

Bidirectional communication between bone marrow stromal cell-derived extracellular vesicles and immune cells contributes to EV-mediated regulation in bone microenvironments.

Quoted textsource-backed
Bidirectional communication between bone marrow stromal cell-derived EVs and immune cells further highlights the complexity of EV-mediated regulation in bone microenvironments.
Claim 4mechanistic rolesupports2025Source 1DOIPubMed

Immunocyte-derived extracellular vesicles regulate bone remodeling by modulating osteoblast and osteoclast activity through macrophage polarization, Treg-associated CD73/adenosine signaling, Th17/Treg balance, and B cell-bone interactions.

Quoted textsource-backed
Immunocyte-derived EVs modulate osteoblast and osteoclast activity through macrophage polarization, Treg-associated CD73/adenosine signaling, Th17/Treg balance, and B cell-bone interactions
Claim 5translational limitationsupports2025Source 1DOIPubMed

The clinical utility of immunocyte-derived and engineered extracellular vesicles is limited by challenges in EV standardization, scalable production, and clinical translation.

Quoted textsource-backed
challenges remain in EV standardization, scalable production, and clinical translation